Abstract
Related Posts
- [Comment] Adjuvant immune checkpoint blockade revisited
An analysis of the costs of 11 US Food and Drug Administration-approved adjuvant therapies shows…
- 1187 Antibody-lectin bispecifics for glyco-immune checkpoint blockade
Background Despite the curative potential of checkpoint blockade immunotherapy, a majority of patients remain unresponsive…
- Downregulation of phosphoserine phosphatase potentiates tumor immune environments to enhance immune checkpoint blockade therapy
Background Effects of immune checkpoint blockade (ICB) treatment in hepatocellular carcinoma (HCC) are limited. The…